nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilotinib—MAPK8—hypertension	0.139	0.51	CbGaD
Nilotinib—PDGFRB—hypertension	0.0791	0.29	CbGaD
Nilotinib—CA9—hypertension	0.0544	0.2	CbGaD
Nilotinib—CA7—Metolazone—hypertension	0.0105	0.0247	CbGbCtD
Nilotinib—CA14—Hydroflumethiazide—hypertension	0.0102	0.024	CbGbCtD
Nilotinib—CA1—Chlorothiazide—hypertension	0.00964	0.0226	CbGbCtD
Nilotinib—CA7—Chlorthalidone—hypertension	0.0091	0.0214	CbGbCtD
Nilotinib—CA4—Chlorothiazide—hypertension	0.00907	0.0213	CbGbCtD
Nilotinib—CA12—Metolazone—hypertension	0.00901	0.0212	CbGbCtD
Nilotinib—CA9—Metolazone—hypertension	0.00901	0.0212	CbGbCtD
Nilotinib—CA1—Bendroflumethiazide—hypertension	0.00897	0.0211	CbGbCtD
Nilotinib—CA7—Indapamide—hypertension	0.00876	0.0206	CbGbCtD
Nilotinib—CA14—Bumetanide—hypertension	0.00851	0.02	CbGbCtD
Nilotinib—CA7—Hydroflumethiazide—hypertension	0.00846	0.0199	CbGbCtD
Nilotinib—CA4—Bendroflumethiazide—hypertension	0.00843	0.0198	CbGbCtD
Nilotinib—CA2—Chlorothiazide—hypertension	0.00833	0.0196	CbGbCtD
Nilotinib—CA4—Metolazone—hypertension	0.00793	0.0186	CbGbCtD
Nilotinib—CA12—Chlorthalidone—hypertension	0.00781	0.0183	CbGbCtD
Nilotinib—CA9—Chlorthalidone—hypertension	0.00781	0.0183	CbGbCtD
Nilotinib—CA2—Bendroflumethiazide—hypertension	0.00775	0.0182	CbGbCtD
Nilotinib—CA9—Indapamide—hypertension	0.00752	0.0177	CbGbCtD
Nilotinib—CA12—Indapamide—hypertension	0.00752	0.0177	CbGbCtD
Nilotinib—CA1—Chlorthalidone—hypertension	0.00731	0.0172	CbGbCtD
Nilotinib—CA9—Hydroflumethiazide—hypertension	0.00726	0.0171	CbGbCtD
Nilotinib—CA12—Hydroflumethiazide—hypertension	0.00726	0.0171	CbGbCtD
Nilotinib—CA7—Bumetanide—hypertension	0.00704	0.0165	CbGbCtD
Nilotinib—CA4—Chlorthalidone—hypertension	0.00687	0.0161	CbGbCtD
Nilotinib—CA1—Hydroflumethiazide—hypertension	0.00679	0.016	CbGbCtD
Nilotinib—CA4—Indapamide—hypertension	0.00662	0.0155	CbGbCtD
Nilotinib—CA4—Hydroflumethiazide—hypertension	0.00639	0.015	CbGbCtD
Nilotinib—CA2—Chlorthalidone—hypertension	0.00632	0.0148	CbGbCtD
Nilotinib—CA9—Hydrochlorothiazide—hypertension	0.00618	0.0145	CbGbCtD
Nilotinib—CA12—Hydrochlorothiazide—hypertension	0.00618	0.0145	CbGbCtD
Nilotinib—CA2—Indapamide—hypertension	0.00608	0.0143	CbGbCtD
Nilotinib—CA12—Bumetanide—hypertension	0.00604	0.0142	CbGbCtD
Nilotinib—CA9—Bumetanide—hypertension	0.00604	0.0142	CbGbCtD
Nilotinib—CA2—Hydroflumethiazide—hypertension	0.00587	0.0138	CbGbCtD
Nilotinib—CA1—Hydrochlorothiazide—hypertension	0.00578	0.0136	CbGbCtD
Nilotinib—CA14—Furosemide—hypertension	0.00548	0.0129	CbGbCtD
Nilotinib—CA4—Hydrochlorothiazide—hypertension	0.00543	0.0128	CbGbCtD
Nilotinib—CA1—Amlodipine—hypertension	0.00543	0.0128	CbGbCtD
Nilotinib—CA4—Bumetanide—hypertension	0.00532	0.0125	CbGbCtD
Nilotinib—CA6—Furosemide—hypertension	0.00521	0.0122	CbGbCtD
Nilotinib—CA2—Hydrochlorothiazide—hypertension	0.00499	0.0117	CbGbCtD
Nilotinib—CA7—Furosemide—hypertension	0.00454	0.0107	CbGbCtD
Nilotinib—CA12—Furosemide—hypertension	0.00389	0.00914	CbGbCtD
Nilotinib—CA9—Furosemide—hypertension	0.00389	0.00914	CbGbCtD
Nilotinib—CA1—Furosemide—hypertension	0.00364	0.00855	CbGbCtD
Nilotinib—CA4—Furosemide—hypertension	0.00343	0.00804	CbGbCtD
Nilotinib—CA2—Furosemide—hypertension	0.00315	0.00739	CbGbCtD
Nilotinib—UGT1A1—Atorvastatin—hypertension	0.00292	0.00684	CbGbCtD
Nilotinib—UGT1A1—Losartan—hypertension	0.00267	0.00626	CbGbCtD
Nilotinib—ABCG2—Telmisartan—hypertension	0.00262	0.00616	CbGbCtD
Nilotinib—ABCG2—Prazosin—hypertension	0.00237	0.00557	CbGbCtD
Nilotinib—CYP2C8—Torasemide—hypertension	0.00211	0.00496	CbGbCtD
Nilotinib—CYP2C8—Candesartan—hypertension	0.00196	0.00461	CbGbCtD
Nilotinib—CYP2C9—Eprosartan—hypertension	0.00181	0.00424	CbGbCtD
Nilotinib—CYP2B6—Amlodipine—hypertension	0.00157	0.00369	CbGbCtD
Nilotinib—ABCB1—Nadolol—hypertension	0.00156	0.00367	CbGbCtD
Nilotinib—CYP2C8—Diltiazem—hypertension	0.00149	0.00349	CbGbCtD
Nilotinib—CYP2C9—Torasemide—hypertension	0.00147	0.00346	CbGbCtD
Nilotinib—CYP2D6—Labetalol—hypertension	0.00147	0.00346	CbGbCtD
Nilotinib—CYP2D6—Nebivolol—hypertension	0.00147	0.00346	CbGbCtD
Nilotinib—CYP2B6—Nifedipine—hypertension	0.00146	0.00344	CbGbCtD
Nilotinib—CYP2B6—Nicardipine—hypertension	0.00144	0.00338	CbGbCtD
Nilotinib—ABCB1—Acebutolol—hypertension	0.00143	0.00335	CbGbCtD
Nilotinib—CYP2C9—Guanfacine—hypertension	0.00137	0.00321	CbGbCtD
Nilotinib—CYP2C9—Candesartan—hypertension	0.00137	0.00321	CbGbCtD
Nilotinib—CYP2D6—Acebutolol—hypertension	0.00135	0.00316	CbGbCtD
Nilotinib—ABCB1—Metoprolol—hypertension	0.00133	0.00312	CbGbCtD
Nilotinib—ABCB1—Candesartan—hypertension	0.00133	0.00312	CbGbCtD
Nilotinib—ABCG2—Verapamil—hypertension	0.00129	0.00304	CbGbCtD
Nilotinib—CYP2D6—Metoprolol—hypertension	0.00125	0.00294	CbGbCtD
Nilotinib—CYP2D6—Pindolol—hypertension	0.00125	0.00294	CbGbCtD
Nilotinib—ABCB1—Terazosin—hypertension	0.00125	0.00293	CbGbCtD
Nilotinib—CYP3A4—Guanethidine—hypertension	0.00123	0.0029	CbGbCtD
Nilotinib—CYP2C8—Irbesartan—hypertension	0.00121	0.00285	CbGbCtD
Nilotinib—CYP2C8—Amlodipine—hypertension	0.00119	0.00279	CbGbCtD
Nilotinib—ABCB1—Reserpine—hypertension	0.00118	0.00278	CbGbCtD
Nilotinib—CYP2C8—Spironolactone—hypertension	0.00117	0.00274	CbGbCtD
Nilotinib—CYP2C8—Felodipine—hypertension	0.00115	0.00269	CbGbCtD
Nilotinib—CYP2B6—Atorvastatin—hypertension	0.00113	0.00265	CbGbCtD
Nilotinib—CYP2D6—Betaxolol—hypertension	0.00112	0.00262	CbGbCtD
Nilotinib—CYP2C8—Nifedipine—hypertension	0.00111	0.0026	CbGbCtD
Nilotinib—CYP2C8—Nicardipine—hypertension	0.00109	0.00256	CbGbCtD
Nilotinib—ABCB1—Perindopril—hypertension	0.00108	0.00254	CbGbCtD
Nilotinib—ABCB1—Doxazosin—hypertension	0.00104	0.00245	CbGbCtD
Nilotinib—ABCB1—Nisoldipine—hypertension	0.00104	0.00245	CbGbCtD
Nilotinib—CYP2C9—Diltiazem—hypertension	0.00104	0.00244	CbGbCtD
Nilotinib—ABCB1—Diltiazem—hypertension	0.00101	0.00236	CbGbCtD
Nilotinib—CYP2D6—Doxazosin—hypertension	0.000982	0.00231	CbGbCtD
Nilotinib—CYP2C9—Valsartan—hypertension	0.000949	0.00223	CbGbCtD
Nilotinib—CYP2D6—Diltiazem—hypertension	0.000948	0.00223	CbGbCtD
Nilotinib—ABCB1—Telmisartan—hypertension	0.000946	0.00222	CbGbCtD
Nilotinib—CYP3A4—Hydralazine—hypertension	0.000936	0.0022	CbGbCtD
Nilotinib—CYP2B6—Verapamil—hypertension	0.00091	0.00214	CbGbCtD
Nilotinib—ABCB1—Bepridil—hypertension	0.000897	0.00211	CbGbCtD
Nilotinib—ABCB1—Lisinopril—hypertension	0.000897	0.00211	CbGbCtD
Nilotinib—ABCB1—Enalapril—hypertension	0.000897	0.00211	CbGbCtD
Nilotinib—ABCB1—Prazosin—hypertension	0.000856	0.00201	CbGbCtD
Nilotinib—CYP2C8—Atorvastatin—hypertension	0.000854	0.00201	CbGbCtD
Nilotinib—CYP2C9—Irbesartan—hypertension	0.000846	0.00199	CbGbCtD
Nilotinib—CYP2D6—Bepridil—hypertension	0.000845	0.00198	CbGbCtD
Nilotinib—CYP2C9—Amlodipine—hypertension	0.000829	0.00195	CbGbCtD
Nilotinib—ABCB1—Amlodipine—hypertension	0.000805	0.00189	CbGbCtD
Nilotinib—CYP2C9—Felodipine—hypertension	0.0008	0.00188	CbGbCtD
Nilotinib—CYP3A4—Guanfacine—hypertension	0.000796	0.00187	CbGbCtD
Nilotinib—ABCB1—Spironolactone—hypertension	0.00079	0.00185	CbGbCtD
Nilotinib—CYP2C8—Losartan—hypertension	0.000781	0.00183	CbGbCtD
Nilotinib—ABCB1—Felodipine—hypertension	0.000776	0.00182	CbGbCtD
Nilotinib—CYP2C9—Nifedipine—hypertension	0.000773	0.00182	CbGbCtD
Nilotinib—CYP2D6—Irbesartan—hypertension	0.000773	0.00182	CbGbCtD
Nilotinib—ABCB1—Timolol—hypertension	0.000763	0.00179	CbGbCtD
Nilotinib—CYP2C9—Nicardipine—hypertension	0.000761	0.00179	CbGbCtD
Nilotinib—CYP2C9—Carvedilol—hypertension	0.000761	0.00179	CbGbCtD
Nilotinib—CYP2D6—Amlodipine—hypertension	0.000758	0.00178	CbGbCtD
Nilotinib—ABCB1—Nifedipine—hypertension	0.000751	0.00176	CbGbCtD
Nilotinib—ABCB1—Nicardipine—hypertension	0.000739	0.00173	CbGbCtD
Nilotinib—ABCB1—Carvedilol—hypertension	0.000739	0.00173	CbGbCtD
Nilotinib—CYP2D6—Felodipine—hypertension	0.000731	0.00172	CbGbCtD
Nilotinib—CYP2D6—Timolol—hypertension	0.000719	0.00169	CbGbCtD
Nilotinib—CYP3A4—Isradipine—hypertension	0.000709	0.00167	CbGbCtD
Nilotinib—CYP2D6—Nifedipine—hypertension	0.000707	0.00166	CbGbCtD
Nilotinib—CYP2D6—Nicardipine—hypertension	0.000696	0.00163	CbGbCtD
Nilotinib—CYP2D6—Carvedilol—hypertension	0.000696	0.00163	CbGbCtD
Nilotinib—CYP2C8—Verapamil—hypertension	0.000689	0.00162	CbGbCtD
Nilotinib—ABCB1—Propranolol—hypertension	0.00068	0.0016	CbGbCtD
Nilotinib—ABCB1—Captopril—hypertension	0.000672	0.00158	CbGbCtD
Nilotinib—Ponatinib—FGFR1—hypertension	0.000664	0.257	CrCbGaD
Nilotinib—ABCB1—Clonidine—hypertension	0.000649	0.00152	CbGbCtD
Nilotinib—CYP2D6—Propranolol—hypertension	0.000641	0.0015	CbGbCtD
Nilotinib—CYP2D6—Captopril—hypertension	0.000633	0.00149	CbGbCtD
Nilotinib—CYP3A4—Nisoldipine—hypertension	0.000624	0.00147	CbGbCtD
Nilotinib—CYP3A4—Indapamide—hypertension	0.000624	0.00147	CbGbCtD
Nilotinib—CYP2D6—Clonidine—hypertension	0.000611	0.00144	CbGbCtD
Nilotinib—CYP3A4—Diltiazem—hypertension	0.000603	0.00142	CbGbCtD
Nilotinib—CYP3A4—Eplerenone—hypertension	0.000603	0.00142	CbGbCtD
Nilotinib—CYP2C9—Atorvastatin—hypertension	0.000596	0.0014	CbGbCtD
Nilotinib—ABCB1—Atorvastatin—hypertension	0.000578	0.00136	CbGbCtD
Nilotinib—CYP2C9—Losartan—hypertension	0.000545	0.00128	CbGbCtD
Nilotinib—CYP2D6—Atorvastatin—hypertension	0.000545	0.00128	CbGbCtD
Nilotinib—CYP3A4—Enalapril—hypertension	0.000538	0.00126	CbGbCtD
Nilotinib—ABCB1—Losartan—hypertension	0.000529	0.00124	CbGbCtD
Nilotinib—CYP3A4—Irbesartan—hypertension	0.000492	0.00115	CbGbCtD
Nilotinib—CYP3A4—Amlodipine—hypertension	0.000482	0.00113	CbGbCtD
Nilotinib—CYP2C9—Verapamil—hypertension	0.000481	0.00113	CbGbCtD
Nilotinib—ABCB1—Verapamil—hypertension	0.000467	0.0011	CbGbCtD
Nilotinib—CYP3A4—Felodipine—hypertension	0.000465	0.00109	CbGbCtD
Nilotinib—CYP3A4—Nifedipine—hypertension	0.00045	0.00106	CbGbCtD
Nilotinib—CYP3A4—Nicardipine—hypertension	0.000443	0.00104	CbGbCtD
Nilotinib—CYP3A4—Carvedilol—hypertension	0.000443	0.00104	CbGbCtD
Nilotinib—CYP2D6—Verapamil—hypertension	0.00044	0.00103	CbGbCtD
Nilotinib—Ponatinib—SRC—hypertension	0.000424	0.164	CrCbGaD
Nilotinib—CYP3A4—Propranolol—hypertension	0.000407	0.000957	CbGbCtD
Nilotinib—Ponatinib—KDR—hypertension	0.000398	0.154	CrCbGaD
Nilotinib—CYP3A4—Clonidine—hypertension	0.000389	0.000912	CbGbCtD
Nilotinib—CYP3A4—Atorvastatin—hypertension	0.000346	0.000813	CbGbCtD
Nilotinib—Imatinib—PDGFRB—hypertension	0.000323	0.125	CrCbGaD
Nilotinib—CYP3A4—Losartan—hypertension	0.000317	0.000744	CbGbCtD
Nilotinib—CYP3A4—Verapamil—hypertension	0.00028	0.000656	CbGbCtD
Nilotinib—Ponatinib—CYP3A5—hypertension	0.00024	0.0929	CrCbGaD
Nilotinib—Imatinib—CA9—hypertension	0.000222	0.0859	CrCbGaD
Nilotinib—HCK—decidua—hypertension	0.000214	0.00404	CbGeAlD
Nilotinib—MAPK14—brainstem—hypertension	0.000214	0.00403	CbGeAlD
Nilotinib—EPHB2—central nervous system—hypertension	0.000212	0.004	CbGeAlD
Nilotinib—CDC42BPB—endocrine gland—hypertension	0.000208	0.00393	CbGeAlD
Nilotinib—EPHA8—central nervous system—hypertension	0.000203	0.00384	CbGeAlD
Nilotinib—EPHA4—heart—hypertension	0.0002	0.00378	CbGeAlD
Nilotinib—CA7—kidney—hypertension	0.000199	0.00376	CbGeAlD
Nilotinib—CA3—heart—hypertension	0.000198	0.00373	CbGeAlD
Nilotinib—MAP4K1—adrenal gland—hypertension	0.000197	0.00372	CbGeAlD
Nilotinib—MAP2K5—myocardium—hypertension	0.000196	0.0037	CbGeAlD
Nilotinib—MAPK11—central nervous system—hypertension	0.000189	0.00357	CbGeAlD
Nilotinib—MAPK8—endocrine gland—hypertension	0.000188	0.00355	CbGeAlD
Nilotinib—EPHA6—endocrine gland—hypertension	0.000188	0.00355	CbGeAlD
Nilotinib—TIE1—adrenal gland—hypertension	0.000188	0.00355	CbGeAlD
Nilotinib—CDC42BPB—central nervous system—hypertension	0.000188	0.00354	CbGeAlD
Nilotinib—CA3—cardiovascular system—hypertension	0.000187	0.00352	CbGeAlD
Nilotinib—MAPK14—heart—hypertension	0.000185	0.00348	CbGeAlD
Nilotinib—LCK—heart—hypertension	0.000184	0.00347	CbGeAlD
Nilotinib—FGR—heart—hypertension	0.000184	0.00347	CbGeAlD
Nilotinib—EPHB4—nephron tubule—hypertension	0.000184	0.00347	CbGeAlD
Nilotinib—MAPK14—smooth muscle tissue—hypertension	0.000183	0.00346	CbGeAlD
Nilotinib—CYP3A4—urine—hypertension	0.000181	0.00342	CbGeAlD
Nilotinib—EPHB4—adrenal cortex—hypertension	0.000181	0.00342	CbGeAlD
Nilotinib—PDGFRB—cardiac ventricle—hypertension	0.000181	0.00341	CbGeAlD
Nilotinib—EPHA2—nephron tubule—hypertension	0.000181	0.0034	CbGeAlD
Nilotinib—BRAF—adrenal gland—hypertension	0.00018	0.0034	CbGeAlD
Nilotinib—CA14—heart—hypertension	0.00018	0.00339	CbGeAlD
Nilotinib—MAPK14—decidua—hypertension	0.00018	0.00339	CbGeAlD
Nilotinib—EPHB3—adrenal gland—hypertension	0.000179	0.00338	CbGeAlD
Nilotinib—FGR—decidua—hypertension	0.000179	0.00338	CbGeAlD
Nilotinib—LCK—decidua—hypertension	0.000179	0.00338	CbGeAlD
Nilotinib—CYP2D6—urine—hypertension	0.000178	0.00336	CbGeAlD
Nilotinib—EPHA3—central nervous system—hypertension	0.000178	0.00335	CbGeAlD
Nilotinib—HCK—medulla oblongata—hypertension	0.000178	0.00335	CbGeAlD
Nilotinib—EPHA2—adrenal cortex—hypertension	0.000178	0.00335	CbGeAlD
Nilotinib—EPHB4—heart—hypertension	0.000175	0.0033	CbGeAlD
Nilotinib—MAPK14—cardiovascular system—hypertension	0.000174	0.00329	CbGeAlD
Nilotinib—KIT—myocardium—hypertension	0.000174	0.00328	CbGeAlD
Nilotinib—LYN—endocrine gland—hypertension	0.000174	0.00328	CbGeAlD
Nilotinib—EPHB4—smooth muscle tissue—hypertension	0.000174	0.00328	CbGeAlD
Nilotinib—FGR—cardiovascular system—hypertension	0.000174	0.00327	CbGeAlD
Nilotinib—TEK—adrenal cortex—hypertension	0.000173	0.00327	CbGeAlD
Nilotinib—EPHA2—heart—hypertension	0.000172	0.00324	CbGeAlD
Nilotinib—EPHA4—cardiac atrium—hypertension	0.000171	0.00323	CbGeAlD
Nilotinib—MAPK14—kidney—hypertension	0.000171	0.00322	CbGeAlD
Nilotinib—EPHB4—decidua—hypertension	0.00017	0.00321	CbGeAlD
Nilotinib—PDGFRB—myocardium—hypertension	0.00017	0.0032	CbGeAlD
Nilotinib—MAPK8—central nervous system—hypertension	0.00017	0.0032	CbGeAlD
Nilotinib—EPHA6—central nervous system—hypertension	0.00017	0.0032	CbGeAlD
Nilotinib—CA3—cardiac atrium—hypertension	0.000169	0.00319	CbGeAlD
Nilotinib—TEK—heart—hypertension	0.000168	0.00316	CbGeAlD
Nilotinib—EPHA2—decidua—hypertension	0.000167	0.00315	CbGeAlD
Nilotinib—TEK—smooth muscle tissue—hypertension	0.000166	0.00314	CbGeAlD
Nilotinib—EPHB4—cardiovascular system—hypertension	0.000165	0.00312	CbGeAlD
Nilotinib—HCK—adrenal gland—hypertension	0.000165	0.0031	CbGeAlD
Nilotinib—ABL2—adrenal gland—hypertension	0.000164	0.00308	CbGeAlD
Nilotinib—TEK—decidua—hypertension	0.000163	0.00307	CbGeAlD
Nilotinib—EPHA2—cardiovascular system—hypertension	0.000162	0.00306	CbGeAlD
Nilotinib—EPHB4—kidney—hypertension	0.000162	0.00305	CbGeAlD
Nilotinib—EPHA4—medulla oblongata—hypertension	0.000162	0.00305	CbGeAlD
Nilotinib—ABL1—cardiac ventricle—hypertension	0.000161	0.00304	CbGeAlD
Nilotinib—EPHB6—heart—hypertension	0.00016	0.00302	CbGeAlD
Nilotinib—MAP2K5—brainstem—hypertension	0.000158	0.00299	CbGeAlD
Nilotinib—TEK—cardiovascular system—hypertension	0.000158	0.00298	CbGeAlD
Nilotinib—EPHB4—cortex of kidney—hypertension	0.000157	0.00297	CbGeAlD
Nilotinib—LYN—central nervous system—hypertension	0.000157	0.00295	CbGeAlD
Nilotinib—EPHB6—decidua—hypertension	0.000156	0.00294	CbGeAlD
Nilotinib—TEK—kidney—hypertension	0.000155	0.00292	CbGeAlD
Nilotinib—CA14—cardiac atrium—hypertension	0.000154	0.0029	CbGeAlD
Nilotinib—PDGFRA—heart—hypertension	0.000152	0.00286	CbGeAlD
Nilotinib—ABL1—myocardium—hypertension	0.000151	0.00286	CbGeAlD
Nilotinib—TEK—cortex of kidney—hypertension	0.000151	0.00284	CbGeAlD
Nilotinib—PDGFRA—smooth muscle tissue—hypertension	0.000151	0.00284	CbGeAlD
Nilotinib—EPHB4—cardiac atrium—hypertension	0.00015	0.00283	CbGeAlD
Nilotinib—EPHA4—adrenal gland—hypertension	0.00015	0.00282	CbGeAlD
Nilotinib—Imatinib—CYP3A5—hypertension	0.000148	0.0572	CrCbGaD
Nilotinib—PDGFRA—decidua—hypertension	0.000148	0.00279	CbGeAlD
Nilotinib—TIE1—central nervous system—hypertension	0.000147	0.00277	CbGeAlD
Nilotinib—EPHA2—cardiac atrium—hypertension	0.000147	0.00277	CbGeAlD
Nilotinib—CA14—medulla oblongata—hypertension	0.000145	0.00273	CbGeAlD
Nilotinib—EPHB6—cortex of kidney—hypertension	0.000144	0.00272	CbGeAlD
Nilotinib—TEK—cardiac atrium—hypertension	0.000143	0.0027	CbGeAlD
Nilotinib—PDGFRA—cardiovascular system—hypertension	0.000143	0.0027	CbGeAlD
Nilotinib—HCK—endocrine gland—hypertension	0.000143	0.00269	CbGeAlD
Nilotinib—MAP2K5—adrenal cortex—hypertension	0.000142	0.00267	CbGeAlD
Nilotinib—EPHB4—medulla oblongata—hypertension	0.000141	0.00266	CbGeAlD
Nilotinib—KIT—brainstem—hypertension	0.00014	0.00265	CbGeAlD
Nilotinib—EPHB3—central nervous system—hypertension	0.00014	0.00264	CbGeAlD
Nilotinib—CSF1R—adrenal cortex—hypertension	0.000138	0.00261	CbGeAlD
Nilotinib—MAPK14—adrenal gland—hypertension	0.000138	0.0026	CbGeAlD
Nilotinib—LCK—adrenal gland—hypertension	0.000137	0.00259	CbGeAlD
Nilotinib—FGR—adrenal gland—hypertension	0.000137	0.00259	CbGeAlD
Nilotinib—EPHB6—cardiac atrium—hypertension	0.000137	0.00258	CbGeAlD
Nilotinib—MAP2K5—heart—hypertension	0.000137	0.00258	CbGeAlD
Nilotinib—TEK—medulla oblongata—hypertension	0.000135	0.00255	CbGeAlD
Nilotinib—CA14—adrenal gland—hypertension	0.000134	0.00253	CbGeAlD
Nilotinib—UGT1A1—kidney—hypertension	0.000134	0.00252	CbGeAlD
Nilotinib—CSF1R—heart—hypertension	0.000134	0.00252	CbGeAlD
Nilotinib—MAP2K5—decidua—hypertension	0.000133	0.00251	CbGeAlD
Nilotinib—CSF1R—smooth muscle tissue—hypertension	0.000133	0.0025	CbGeAlD
Nilotinib—CA4—cardiac ventricle—hypertension	0.000132	0.00249	CbGeAlD
Nilotinib—EPHB4—adrenal gland—hypertension	0.000131	0.00247	CbGeAlD
Nilotinib—CSF1R—decidua—hypertension	0.00013	0.00245	CbGeAlD
Nilotinib—EPHA4—endocrine gland—hypertension	0.00013	0.00245	CbGeAlD
Nilotinib—CA12—kidney—hypertension	0.000129	0.00244	CbGeAlD
Nilotinib—MAP2K5—cardiovascular system—hypertension	0.000129	0.00244	CbGeAlD
Nilotinib—EPHB6—medulla oblongata—hypertension	0.000129	0.00244	CbGeAlD
Nilotinib—HCK—central nervous system—hypertension	0.000129	0.00243	CbGeAlD
Nilotinib—EPHA2—adrenal gland—hypertension	0.000128	0.00242	CbGeAlD
Nilotinib—CA3—endocrine gland—hypertension	0.000128	0.00242	CbGeAlD
Nilotinib—KIT—nephron tubule—hypertension	0.000128	0.00241	CbGeAlD
Nilotinib—CSF1R—cardiovascular system—hypertension	0.000126	0.00238	CbGeAlD
Nilotinib—TEK—adrenal gland—hypertension	0.000125	0.00236	CbGeAlD
Nilotinib—CA4—myocardium—hypertension	0.000124	0.00234	CbGeAlD
Nilotinib—MAP2K5—cortex of kidney—hypertension	0.000123	0.00232	CbGeAlD
Nilotinib—CA9—endocrine gland—hypertension	0.000123	0.00231	CbGeAlD
Nilotinib—PDGFRB—adrenal cortex—hypertension	0.000123	0.00231	CbGeAlD
Nilotinib—ABL1—brainstem—hypertension	0.000122	0.0023	CbGeAlD
Nilotinib—KIT—heart—hypertension	0.000121	0.00229	CbGeAlD
Nilotinib—KIT—smooth muscle tissue—hypertension	0.00012	0.00227	CbGeAlD
Nilotinib—MAPK14—endocrine gland—hypertension	0.00012	0.00226	CbGeAlD
Nilotinib—EPHB6—adrenal gland—hypertension	0.00012	0.00225	CbGeAlD
Nilotinib—FGR—endocrine gland—hypertension	0.000119	0.00225	CbGeAlD
Nilotinib—PDGFRB—heart—hypertension	0.000119	0.00224	CbGeAlD
Nilotinib—KIT—decidua—hypertension	0.000118	0.00223	CbGeAlD
Nilotinib—PDGFRB—smooth muscle tissue—hypertension	0.000118	0.00222	CbGeAlD
Nilotinib—MAP2K5—cardiac atrium—hypertension	0.000117	0.00221	CbGeAlD
Nilotinib—EPHA4—central nervous system—hypertension	0.000117	0.0022	CbGeAlD
Nilotinib—CA3—central nervous system—hypertension	0.000115	0.00218	CbGeAlD
Nilotinib—PDGFRB—decidua—hypertension	0.000115	0.00217	CbGeAlD
Nilotinib—KIT—cardiovascular system—hypertension	0.000115	0.00216	CbGeAlD
Nilotinib—CSF1R—cardiac atrium—hypertension	0.000114	0.00216	CbGeAlD
Nilotinib—EPHB4—endocrine gland—hypertension	0.000113	0.00214	CbGeAlD
Nilotinib—PDGFRA—adrenal gland—hypertension	0.000113	0.00214	CbGeAlD
Nilotinib—KIT—kidney—hypertension	0.000112	0.00211	CbGeAlD
Nilotinib—PDGFRB—cardiovascular system—hypertension	0.000112	0.00211	CbGeAlD
Nilotinib—EPHA2—endocrine gland—hypertension	0.000111	0.0021	CbGeAlD
Nilotinib—CA1—heart—hypertension	0.000111	0.00209	CbGeAlD
Nilotinib—ABL1—nephron tubule—hypertension	0.000111	0.00209	CbGeAlD
Nilotinib—MAP2K5—medulla oblongata—hypertension	0.00011	0.00208	CbGeAlD
Nilotinib—Imatinib—PTGS1—hypertension	0.00011	0.0424	CrCbGaD
Nilotinib—CA2—cardiac ventricle—hypertension	0.00011	0.00207	CbGeAlD
Nilotinib—PDGFRB—kidney—hypertension	0.000109	0.00206	CbGeAlD
Nilotinib—ABL1—adrenal cortex—hypertension	0.000109	0.00206	CbGeAlD
Nilotinib—KIT—cortex of kidney—hypertension	0.000109	0.00206	CbGeAlD
Nilotinib—TEK—endocrine gland—hypertension	0.000108	0.00205	CbGeAlD
Nilotinib—CSF1R—medulla oblongata—hypertension	0.000108	0.00203	CbGeAlD
Nilotinib—MAPK14—central nervous system—hypertension	0.000108	0.00203	CbGeAlD
Nilotinib—FGR—central nervous system—hypertension	0.000107	0.00202	CbGeAlD
Nilotinib—PDGFRB—cortex of kidney—hypertension	0.000107	0.00201	CbGeAlD
Nilotinib—ABL1—heart—hypertension	0.000106	0.00199	CbGeAlD
Nilotinib—ABL1—smooth muscle tissue—hypertension	0.000105	0.00198	CbGeAlD
Nilotinib—CA1—cardiovascular system—hypertension	0.000105	0.00198	CbGeAlD
Nilotinib—CA2—myocardium—hypertension	0.000103	0.00194	CbGeAlD
Nilotinib—ABL1—decidua—hypertension	0.000103	0.00194	CbGeAlD
Nilotinib—CA1—kidney—hypertension	0.000103	0.00193	CbGeAlD
Nilotinib—MAP2K5—adrenal gland—hypertension	0.000102	0.00193	CbGeAlD
Nilotinib—PDGFRB—cardiac atrium—hypertension	0.000101	0.00191	CbGeAlD
Nilotinib—CA4—brainstem—hypertension	0.0001	0.00189	CbGeAlD
Nilotinib—EPHA2—central nervous system—hypertension	0.0001	0.00189	CbGeAlD
Nilotinib—CSF1R—adrenal gland—hypertension	9.98e-05	0.00188	CbGeAlD
Nilotinib—ABL1—cardiovascular system—hypertension	9.97e-05	0.00188	CbGeAlD
Nilotinib—PDGFRA—endocrine gland—hypertension	9.83e-05	0.00185	CbGeAlD
Nilotinib—KIT—medulla oblongata—hypertension	9.79e-05	0.00185	CbGeAlD
Nilotinib—TEK—central nervous system—hypertension	9.78e-05	0.00184	CbGeAlD
Nilotinib—ABL1—kidney—hypertension	9.76e-05	0.00184	CbGeAlD
Nilotinib—PDGFRB—medulla oblongata—hypertension	9.56e-05	0.0018	CbGeAlD
Nilotinib—ABL1—cortex of kidney—hypertension	9.5e-05	0.00179	CbGeAlD
Nilotinib—UGT1A1—endocrine gland—hypertension	9.38e-05	0.00177	CbGeAlD
Nilotinib—EPHB6—central nervous system—hypertension	9.34e-05	0.00176	CbGeAlD
Nilotinib—CA4—nephron tubule—hypertension	9.12e-05	0.00172	CbGeAlD
Nilotinib—CA12—endocrine gland—hypertension	9.07e-05	0.00171	CbGeAlD
Nilotinib—KIT—adrenal gland—hypertension	9.06e-05	0.00171	CbGeAlD
Nilotinib—ABL1—cardiac atrium—hypertension	9.04e-05	0.0017	CbGeAlD
Nilotinib—MAP2K5—endocrine gland—hypertension	8.87e-05	0.00167	CbGeAlD
Nilotinib—PDGFRA—central nervous system—hypertension	8.86e-05	0.00167	CbGeAlD
Nilotinib—PDGFRB—adrenal gland—hypertension	8.85e-05	0.00167	CbGeAlD
Nilotinib—CA4—heart—hypertension	8.68e-05	0.00164	CbGeAlD
Nilotinib—CSF1R—endocrine gland—hypertension	8.65e-05	0.00163	CbGeAlD
Nilotinib—ABL1—medulla oblongata—hypertension	8.52e-05	0.00161	CbGeAlD
Nilotinib—CA2—brainstem—hypertension	8.32e-05	0.00157	CbGeAlD
Nilotinib—CA4—cardiovascular system—hypertension	8.19e-05	0.00154	CbGeAlD
Nilotinib—CA12—central nervous system—hypertension	8.18e-05	0.00154	CbGeAlD
Nilotinib—CA4—kidney—hypertension	8.01e-05	0.00151	CbGeAlD
Nilotinib—MAP2K5—central nervous system—hypertension	7.99e-05	0.00151	CbGeAlD
Nilotinib—ABL1—adrenal gland—hypertension	7.89e-05	0.00149	CbGeAlD
Nilotinib—KIT—endocrine gland—hypertension	7.86e-05	0.00148	CbGeAlD
Nilotinib—CA4—cortex of kidney—hypertension	7.8e-05	0.00147	CbGeAlD
Nilotinib—CSF1R—central nervous system—hypertension	7.8e-05	0.00147	CbGeAlD
Nilotinib—PDGFRB—endocrine gland—hypertension	7.67e-05	0.00145	CbGeAlD
Nilotinib—CA2—nephron tubule—hypertension	7.56e-05	0.00143	CbGeAlD
Nilotinib—CA2—adrenal cortex—hypertension	7.44e-05	0.0014	CbGeAlD
Nilotinib—CA4—cardiac atrium—hypertension	7.42e-05	0.0014	CbGeAlD
Nilotinib—CA2—heart—hypertension	7.2e-05	0.00136	CbGeAlD
Nilotinib—CA1—endocrine gland—hypertension	7.19e-05	0.00136	CbGeAlD
Nilotinib—CA2—smooth muscle tissue—hypertension	7.14e-05	0.00135	CbGeAlD
Nilotinib—KIT—central nervous system—hypertension	7.08e-05	0.00134	CbGeAlD
Nilotinib—ABCG2—nephron tubule—hypertension	7e-05	0.00132	CbGeAlD
Nilotinib—CA2—decidua—hypertension	7e-05	0.00132	CbGeAlD
Nilotinib—CA4—medulla oblongata—hypertension	7e-05	0.00132	CbGeAlD
Nilotinib—ABCB1—blood vessel—hypertension	6.95e-05	0.00131	CbGeAlD
Nilotinib—PDGFRB—central nervous system—hypertension	6.92e-05	0.0013	CbGeAlD
Nilotinib—ABCG2—adrenal cortex—hypertension	6.89e-05	0.0013	CbGeAlD
Nilotinib—ABL1—endocrine gland—hypertension	6.84e-05	0.00129	CbGeAlD
Nilotinib—CA2—cardiovascular system—hypertension	6.79e-05	0.00128	CbGeAlD
Nilotinib—ABCG2—heart—hypertension	6.66e-05	0.00126	CbGeAlD
Nilotinib—CA2—kidney—hypertension	6.64e-05	0.00125	CbGeAlD
Nilotinib—ABCG2—decidua—hypertension	6.48e-05	0.00122	CbGeAlD
Nilotinib—CA4—adrenal gland—hypertension	6.48e-05	0.00122	CbGeAlD
Nilotinib—CA1—central nervous system—hypertension	6.48e-05	0.00122	CbGeAlD
Nilotinib—CA2—cortex of kidney—hypertension	6.47e-05	0.00122	CbGeAlD
Nilotinib—CYP2B6—nephron tubule—hypertension	6.46e-05	0.00122	CbGeAlD
Nilotinib—CYP2B6—adrenal cortex—hypertension	6.36e-05	0.0012	CbGeAlD
Nilotinib—CYP2C8—kidney—hypertension	6.33e-05	0.00119	CbGeAlD
Nilotinib—ABL1—central nervous system—hypertension	6.16e-05	0.00116	CbGeAlD
Nilotinib—CA2—cardiac atrium—hypertension	6.15e-05	0.00116	CbGeAlD
Nilotinib—CYP2B6—heart—hypertension	6.15e-05	0.00116	CbGeAlD
Nilotinib—CYP2C9—heart—hypertension	6.09e-05	0.00115	CbGeAlD
Nilotinib—CA2—medulla oblongata—hypertension	5.8e-05	0.00109	CbGeAlD
Nilotinib—CYP2B6—cardiovascular system—hypertension	5.8e-05	0.00109	CbGeAlD
Nilotinib—CYP2C9—cardiovascular system—hypertension	5.75e-05	0.00108	CbGeAlD
Nilotinib—CYP2B6—kidney—hypertension	5.68e-05	0.00107	CbGeAlD
Nilotinib—CA4—endocrine gland—hypertension	5.62e-05	0.00106	CbGeAlD
Nilotinib—Imatinib—ALB—hypertension	5.58e-05	0.0216	CrCbGaD
Nilotinib—ABCG2—medulla oblongata—hypertension	5.37e-05	0.00101	CbGeAlD
Nilotinib—CA2—adrenal gland—hypertension	5.37e-05	0.00101	CbGeAlD
Nilotinib—CYP2D6—brainstem—hypertension	5.28e-05	0.000996	CbGeAlD
Nilotinib—CA4—central nervous system—hypertension	5.06e-05	0.000955	CbGeAlD
Nilotinib—ABCG2—adrenal gland—hypertension	4.97e-05	0.000938	CbGeAlD
Nilotinib—CA2—endocrine gland—hypertension	4.66e-05	0.000878	CbGeAlD
Nilotinib—CYP2B6—adrenal gland—hypertension	4.59e-05	0.000865	CbGeAlD
Nilotinib—CYP2C8—endocrine gland—hypertension	4.44e-05	0.000837	CbGeAlD
Nilotinib—CYP3A4—kidney—hypertension	4.29e-05	0.000808	CbGeAlD
Nilotinib—CYP2D6—kidney—hypertension	4.22e-05	0.000795	CbGeAlD
Nilotinib—CA2—central nervous system—hypertension	4.2e-05	0.000792	CbGeAlD
Nilotinib—CYP2B6—endocrine gland—hypertension	3.98e-05	0.00075	CbGeAlD
Nilotinib—CYP2C9—endocrine gland—hypertension	3.94e-05	0.000743	CbGeAlD
Nilotinib—CYP2B6—central nervous system—hypertension	3.59e-05	0.000676	CbGeAlD
Nilotinib—ABCB1—nephron tubule—hypertension	3.45e-05	0.000651	CbGeAlD
Nilotinib—ABCB1—adrenal cortex—hypertension	3.4e-05	0.000641	CbGeAlD
Nilotinib—ABCB1—heart—hypertension	3.29e-05	0.00062	CbGeAlD
Nilotinib—ABCB1—decidua—hypertension	3.2e-05	0.000603	CbGeAlD
Nilotinib—ABCB1—cardiovascular system—hypertension	3.1e-05	0.000585	CbGeAlD
Nilotinib—ABCB1—kidney—hypertension	3.03e-05	0.000572	CbGeAlD
Nilotinib—CYP3A4—endocrine gland—hypertension	3e-05	0.000567	CbGeAlD
Nilotinib—CYP2D6—endocrine gland—hypertension	2.96e-05	0.000558	CbGeAlD
Nilotinib—ABCB1—cortex of kidney—hypertension	2.96e-05	0.000557	CbGeAlD
Nilotinib—CYP3A4—central nervous system—hypertension	2.71e-05	0.000511	CbGeAlD
Nilotinib—CYP2D6—central nervous system—hypertension	2.66e-05	0.000503	CbGeAlD
Nilotinib—ABCB1—medulla oblongata—hypertension	2.65e-05	0.0005	CbGeAlD
Nilotinib—ABCB1—adrenal gland—hypertension	2.45e-05	0.000463	CbGeAlD
Nilotinib—ABCB1—endocrine gland—hypertension	2.13e-05	0.000401	CbGeAlD
Nilotinib—ABCB1—central nervous system—hypertension	1.92e-05	0.000361	CbGeAlD
Nilotinib—Dermatitis—Nifedipine—hypertension	9.67e-06	7.04e-05	CcSEcCtD
Nilotinib—Body temperature increased—Irbesartan—hypertension	9.67e-06	7.03e-05	CcSEcCtD
Nilotinib—Abdominal pain—Irbesartan—hypertension	9.67e-06	7.03e-05	CcSEcCtD
Nilotinib—Thrombocytopenia—Ramipril—hypertension	9.66e-06	7.03e-05	CcSEcCtD
Nilotinib—Oedema—Timolol—hypertension	9.65e-06	7.02e-05	CcSEcCtD
Nilotinib—Loss of consciousness—Lisinopril—hypertension	9.64e-06	7.01e-05	CcSEcCtD
Nilotinib—Rash—Verapamil—hypertension	9.64e-06	7.01e-05	CcSEcCtD
Nilotinib—Urticaria—Hydrochlorothiazide—hypertension	9.64e-06	7.01e-05	CcSEcCtD
Nilotinib—Tachycardia—Ramipril—hypertension	9.63e-06	7.01e-05	CcSEcCtD
Nilotinib—Dermatitis—Verapamil—hypertension	9.63e-06	7.01e-05	CcSEcCtD
Nilotinib—Headache—Nifedipine—hypertension	9.62e-06	7e-05	CcSEcCtD
Nilotinib—Pruritus—Clonidine—hypertension	9.6e-06	6.98e-05	CcSEcCtD
Nilotinib—Abdominal pain—Hydrochlorothiazide—hypertension	9.59e-06	6.98e-05	CcSEcCtD
Nilotinib—Body temperature increased—Hydrochlorothiazide—hypertension	9.59e-06	6.98e-05	CcSEcCtD
Nilotinib—Skin disorder—Ramipril—hypertension	9.59e-06	6.98e-05	CcSEcCtD
Nilotinib—Infection—Timolol—hypertension	9.58e-06	6.97e-05	CcSEcCtD
Nilotinib—Headache—Verapamil—hypertension	9.58e-06	6.97e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Telmisartan—hypertension	9.58e-06	6.97e-05	CcSEcCtD
Nilotinib—Cough—Lisinopril—hypertension	9.57e-06	6.96e-05	CcSEcCtD
Nilotinib—Nausea—Diltiazem—hypertension	9.55e-06	6.95e-05	CcSEcCtD
Nilotinib—Nausea—Indapamide—hypertension	9.55e-06	6.95e-05	CcSEcCtD
Nilotinib—Hyperhidrosis—Ramipril—hypertension	9.54e-06	6.94e-05	CcSEcCtD
Nilotinib—Asthenia—Trandolapril—hypertension	9.49e-06	6.91e-05	CcSEcCtD
Nilotinib—Shock—Timolol—hypertension	9.49e-06	6.91e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Losartan—hypertension	9.48e-06	6.9e-05	CcSEcCtD
Nilotinib—Urticaria—Furosemide—hypertension	9.48e-06	6.9e-05	CcSEcCtD
Nilotinib—Nervous system disorder—Timolol—hypertension	9.46e-06	6.88e-05	CcSEcCtD
Nilotinib—Nausea—Carvedilol—hypertension	9.46e-06	6.88e-05	CcSEcCtD
Nilotinib—Asthenia—Enalapril—hypertension	9.45e-06	6.88e-05	CcSEcCtD
Nilotinib—Abdominal pain—Furosemide—hypertension	9.43e-06	6.86e-05	CcSEcCtD
Nilotinib—Body temperature increased—Furosemide—hypertension	9.43e-06	6.86e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Losartan—hypertension	9.41e-06	6.85e-05	CcSEcCtD
Nilotinib—Dizziness—Valsartan—hypertension	9.41e-06	6.85e-05	CcSEcCtD
Nilotinib—Anorexia—Ramipril—hypertension	9.41e-06	6.85e-05	CcSEcCtD
Nilotinib—Urticaria—Betaxolol—hypertension	9.38e-06	6.83e-05	CcSEcCtD
Nilotinib—Skin disorder—Timolol—hypertension	9.37e-06	6.82e-05	CcSEcCtD
Nilotinib—Dizziness—Olmesartan—hypertension	9.37e-06	6.81e-05	CcSEcCtD
Nilotinib—Pruritus—Trandolapril—hypertension	9.36e-06	6.81e-05	CcSEcCtD
Nilotinib—Nausea—Doxazosin—hypertension	9.36e-06	6.81e-05	CcSEcCtD
Nilotinib—Chest pain—Lisinopril—hypertension	9.34e-06	6.79e-05	CcSEcCtD
Nilotinib—Arthralgia—Lisinopril—hypertension	9.34e-06	6.79e-05	CcSEcCtD
Nilotinib—Myalgia—Lisinopril—hypertension	9.34e-06	6.79e-05	CcSEcCtD
Nilotinib—Body temperature increased—Betaxolol—hypertension	9.34e-06	6.79e-05	CcSEcCtD
Nilotinib—Hyperhidrosis—Timolol—hypertension	9.33e-06	6.79e-05	CcSEcCtD
Nilotinib—Asthenia—Telmisartan—hypertension	9.33e-06	6.79e-05	CcSEcCtD
Nilotinib—Pruritus—Enalapril—hypertension	9.32e-06	6.78e-05	CcSEcCtD
Nilotinib—Anxiety—Lisinopril—hypertension	9.3e-06	6.77e-05	CcSEcCtD
Nilotinib—Diarrhoea—Clonidine—hypertension	9.28e-06	6.75e-05	CcSEcCtD
Nilotinib—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—hypertension	9.27e-06	6.75e-05	CcSEcCtD
Nilotinib—Nausea—Fosinopril—hypertension	9.24e-06	6.73e-05	CcSEcCtD
Nilotinib—Discomfort—Lisinopril—hypertension	9.22e-06	6.71e-05	CcSEcCtD
Nilotinib—Hypotension—Ramipril—hypertension	9.22e-06	6.71e-05	CcSEcCtD
Nilotinib—Anorexia—Timolol—hypertension	9.2e-06	6.69e-05	CcSEcCtD
Nilotinib—Pruritus—Telmisartan—hypertension	9.2e-06	6.69e-05	CcSEcCtD
Nilotinib—Nausea—Eplerenone—hypertension	9.19e-06	6.68e-05	CcSEcCtD
Nilotinib—Urticaria—Losartan—hypertension	9.14e-06	6.65e-05	CcSEcCtD
Nilotinib—Dry mouth—Lisinopril—hypertension	9.13e-06	6.64e-05	CcSEcCtD
Nilotinib—Nausea—Nifedipine—hypertension	9.12e-06	6.64e-05	CcSEcCtD
Nilotinib—Abdominal pain—Losartan—hypertension	9.1e-06	6.62e-05	CcSEcCtD
Nilotinib—Body temperature increased—Losartan—hypertension	9.1e-06	6.62e-05	CcSEcCtD
Nilotinib—Nausea—Verapamil—hypertension	9.08e-06	6.61e-05	CcSEcCtD
Nilotinib—Asthenia—Captopril—hypertension	9.07e-06	6.6e-05	CcSEcCtD
Nilotinib—Diarrhoea—Trandolapril—hypertension	9.05e-06	6.59e-05	CcSEcCtD
Nilotinib—Vomiting—Valsartan—hypertension	9.05e-06	6.58e-05	CcSEcCtD
Nilotinib—Confusional state—Lisinopril—hypertension	9.02e-06	6.57e-05	CcSEcCtD
Nilotinib—Diarrhoea—Enalapril—hypertension	9.02e-06	6.56e-05	CcSEcCtD
Nilotinib—Hypotension—Timolol—hypertension	9.02e-06	6.56e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Irbesartan—hypertension	9.01e-06	6.56e-05	CcSEcCtD
Nilotinib—Vomiting—Olmesartan—hypertension	9e-06	6.55e-05	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Ramipril—hypertension	8.99e-06	6.54e-05	CcSEcCtD
Nilotinib—Rash—Valsartan—hypertension	8.97e-06	6.53e-05	CcSEcCtD
Nilotinib—Dizziness—Clonidine—hypertension	8.97e-06	6.53e-05	CcSEcCtD
Nilotinib—Dermatitis—Valsartan—hypertension	8.96e-06	6.52e-05	CcSEcCtD
Nilotinib—Oedema—Lisinopril—hypertension	8.95e-06	6.51e-05	CcSEcCtD
Nilotinib—Pruritus—Captopril—hypertension	8.94e-06	6.51e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Hydrochlorothiazide—hypertension	8.94e-06	6.5e-05	CcSEcCtD
Nilotinib—Rash—Olmesartan—hypertension	8.93e-06	6.5e-05	CcSEcCtD
Nilotinib—Insomnia—Ramipril—hypertension	8.93e-06	6.49e-05	CcSEcCtD
Nilotinib—Dermatitis—Olmesartan—hypertension	8.92e-06	6.49e-05	CcSEcCtD
Nilotinib—Headache—Valsartan—hypertension	8.92e-06	6.49e-05	CcSEcCtD
Nilotinib—Diarrhoea—Telmisartan—hypertension	8.89e-06	6.47e-05	CcSEcCtD
Nilotinib—Infection—Lisinopril—hypertension	8.89e-06	6.47e-05	CcSEcCtD
Nilotinib—Headache—Olmesartan—hypertension	8.87e-06	6.46e-05	CcSEcCtD
Nilotinib—Paraesthesia—Ramipril—hypertension	8.86e-06	6.45e-05	CcSEcCtD
Nilotinib—Shock—Lisinopril—hypertension	8.81e-06	6.41e-05	CcSEcCtD
Nilotinib—Asthenia—Perindopril—hypertension	8.8e-06	6.41e-05	CcSEcCtD
Nilotinib—Dyspnoea—Ramipril—hypertension	8.8e-06	6.4e-05	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Timolol—hypertension	8.79e-06	6.4e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Furosemide—hypertension	8.79e-06	6.39e-05	CcSEcCtD
Nilotinib—Asthenia—Irbesartan—hypertension	8.77e-06	6.38e-05	CcSEcCtD
Nilotinib—Thrombocytopenia—Lisinopril—hypertension	8.76e-06	6.38e-05	CcSEcCtD
Nilotinib—Dizziness—Trandolapril—hypertension	8.75e-06	6.37e-05	CcSEcCtD
Nilotinib—Tachycardia—Lisinopril—hypertension	8.74e-06	6.36e-05	CcSEcCtD
Nilotinib—Insomnia—Timolol—hypertension	8.73e-06	6.35e-05	CcSEcCtD
Nilotinib—Dizziness—Enalapril—hypertension	8.71e-06	6.34e-05	CcSEcCtD
Nilotinib—Asthenia—Hydrochlorothiazide—hypertension	8.7e-06	6.33e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Betaxolol—hypertension	8.7e-06	6.33e-05	CcSEcCtD
Nilotinib—Skin disorder—Lisinopril—hypertension	8.69e-06	6.33e-05	CcSEcCtD
Nilotinib—Dyspepsia—Ramipril—hypertension	8.69e-06	6.32e-05	CcSEcCtD
Nilotinib—Pruritus—Perindopril—hypertension	8.68e-06	6.32e-05	CcSEcCtD
Nilotinib—Paraesthesia—Timolol—hypertension	8.66e-06	6.3e-05	CcSEcCtD
Nilotinib—Pruritus—Irbesartan—hypertension	8.65e-06	6.3e-05	CcSEcCtD
Nilotinib—Hyperhidrosis—Lisinopril—hypertension	8.65e-06	6.3e-05	CcSEcCtD
Nilotinib—Diarrhoea—Captopril—hypertension	8.65e-06	6.29e-05	CcSEcCtD
Nilotinib—Vomiting—Clonidine—hypertension	8.62e-06	6.28e-05	CcSEcCtD
Nilotinib—Dyspnoea—Timolol—hypertension	8.6e-06	6.26e-05	CcSEcCtD
Nilotinib—Dizziness—Telmisartan—hypertension	8.59e-06	6.25e-05	CcSEcCtD
Nilotinib—Pruritus—Hydrochlorothiazide—hypertension	8.58e-06	6.24e-05	CcSEcCtD
Nilotinib—Decreased appetite—Ramipril—hypertension	8.58e-06	6.24e-05	CcSEcCtD
Nilotinib—Asthenia—Furosemide—hypertension	8.56e-06	6.23e-05	CcSEcCtD
Nilotinib—Rash—Clonidine—hypertension	8.55e-06	6.22e-05	CcSEcCtD
Nilotinib—Dermatitis—Clonidine—hypertension	8.55e-06	6.22e-05	CcSEcCtD
Nilotinib—Anorexia—Lisinopril—hypertension	8.53e-06	6.21e-05	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Ramipril—hypertension	8.52e-06	6.2e-05	CcSEcCtD
Nilotinib—Fatigue—Ramipril—hypertension	8.51e-06	6.19e-05	CcSEcCtD
Nilotinib—Headache—Clonidine—hypertension	8.5e-06	6.18e-05	CcSEcCtD
Nilotinib—Dyspepsia—Timolol—hypertension	8.49e-06	6.18e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Losartan—hypertension	8.48e-06	6.17e-05	CcSEcCtD
Nilotinib—Asthenia—Betaxolol—hypertension	8.47e-06	6.17e-05	CcSEcCtD
Nilotinib—Nausea—Valsartan—hypertension	8.45e-06	6.15e-05	CcSEcCtD
Nilotinib—Pruritus—Furosemide—hypertension	8.44e-06	6.14e-05	CcSEcCtD
Nilotinib—Constipation—Ramipril—hypertension	8.44e-06	6.14e-05	CcSEcCtD
Nilotinib—Nausea—Olmesartan—hypertension	8.41e-06	6.12e-05	CcSEcCtD
Nilotinib—Vomiting—Trandolapril—hypertension	8.41e-06	6.12e-05	CcSEcCtD
Nilotinib—Diarrhoea—Perindopril—hypertension	8.4e-06	6.11e-05	CcSEcCtD
Nilotinib—Decreased appetite—Timolol—hypertension	8.39e-06	6.1e-05	CcSEcCtD
Nilotinib—Vomiting—Enalapril—hypertension	8.38e-06	6.1e-05	CcSEcCtD
Nilotinib—Diarrhoea—Irbesartan—hypertension	8.37e-06	6.09e-05	CcSEcCtD
Nilotinib—Hypotension—Lisinopril—hypertension	8.36e-06	6.09e-05	CcSEcCtD
Nilotinib—Dizziness—Captopril—hypertension	8.36e-06	6.08e-05	CcSEcCtD
Nilotinib—Pruritus—Betaxolol—hypertension	8.36e-06	6.08e-05	CcSEcCtD
Nilotinib—Rash—Trandolapril—hypertension	8.34e-06	6.07e-05	CcSEcCtD
Nilotinib—Dermatitis—Trandolapril—hypertension	8.33e-06	6.06e-05	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Timolol—hypertension	8.33e-06	6.06e-05	CcSEcCtD
Nilotinib—Fatigue—Timolol—hypertension	8.32e-06	6.05e-05	CcSEcCtD
Nilotinib—Rash—Enalapril—hypertension	8.31e-06	6.05e-05	CcSEcCtD
Nilotinib—Dermatitis—Enalapril—hypertension	8.3e-06	6.04e-05	CcSEcCtD
Nilotinib—Diarrhoea—Hydrochlorothiazide—hypertension	8.3e-06	6.04e-05	CcSEcCtD
Nilotinib—Headache—Trandolapril—hypertension	8.29e-06	6.03e-05	CcSEcCtD
Nilotinib—Vomiting—Telmisartan—hypertension	8.26e-06	6.01e-05	CcSEcCtD
Nilotinib—Asthenia—Losartan—hypertension	8.26e-06	6.01e-05	CcSEcCtD
Nilotinib—Headache—Enalapril—hypertension	8.25e-06	6.01e-05	CcSEcCtD
Nilotinib—Pain—Timolol—hypertension	8.25e-06	6e-05	CcSEcCtD
Nilotinib—Rash—Telmisartan—hypertension	8.19e-06	5.96e-05	CcSEcCtD
Nilotinib—Dermatitis—Telmisartan—hypertension	8.19e-06	5.96e-05	CcSEcCtD
Nilotinib—Diarrhoea—Furosemide—hypertension	8.16e-06	5.94e-05	CcSEcCtD
Nilotinib—Musculoskeletal discomfort—Lisinopril—hypertension	8.15e-06	5.93e-05	CcSEcCtD
Nilotinib—Pruritus—Losartan—hypertension	8.14e-06	5.93e-05	CcSEcCtD
Nilotinib—Headache—Telmisartan—hypertension	8.14e-06	5.92e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Ramipril—hypertension	8.13e-06	5.92e-05	CcSEcCtD
Nilotinib—Dizziness—Perindopril—hypertension	8.11e-06	5.9e-05	CcSEcCtD
Nilotinib—Insomnia—Lisinopril—hypertension	8.1e-06	5.89e-05	CcSEcCtD
Nilotinib—Dizziness—Irbesartan—hypertension	8.09e-06	5.88e-05	CcSEcCtD
Nilotinib—Diarrhoea—Betaxolol—hypertension	8.08e-06	5.88e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Ramipril—hypertension	8.07e-06	5.87e-05	CcSEcCtD
Nilotinib—Nausea—Clonidine—hypertension	8.06e-06	5.86e-05	CcSEcCtD
Nilotinib—Paraesthesia—Lisinopril—hypertension	8.04e-06	5.85e-05	CcSEcCtD
Nilotinib—Vomiting—Captopril—hypertension	8.04e-06	5.85e-05	CcSEcCtD
Nilotinib—Dizziness—Hydrochlorothiazide—hypertension	8.02e-06	5.84e-05	CcSEcCtD
Nilotinib—Dyspnoea—Lisinopril—hypertension	7.98e-06	5.81e-05	CcSEcCtD
Nilotinib—Rash—Captopril—hypertension	7.97e-06	5.8e-05	CcSEcCtD
Nilotinib—Dermatitis—Captopril—hypertension	7.96e-06	5.79e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Timolol—hypertension	7.95e-06	5.79e-05	CcSEcCtD
Nilotinib—Headache—Captopril—hypertension	7.92e-06	5.76e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Timolol—hypertension	7.89e-06	5.74e-05	CcSEcCtD
Nilotinib—Dizziness—Furosemide—hypertension	7.89e-06	5.74e-05	CcSEcCtD
Nilotinib—Dyspepsia—Lisinopril—hypertension	7.88e-06	5.73e-05	CcSEcCtD
Nilotinib—Diarrhoea—Losartan—hypertension	7.87e-06	5.73e-05	CcSEcCtD
Nilotinib—Nausea—Trandolapril—hypertension	7.86e-06	5.72e-05	CcSEcCtD
Nilotinib—Urticaria—Ramipril—hypertension	7.84e-06	5.7e-05	CcSEcCtD
Nilotinib—Nausea—Enalapril—hypertension	7.83e-06	5.7e-05	CcSEcCtD
Nilotinib—Dizziness—Betaxolol—hypertension	7.81e-06	5.68e-05	CcSEcCtD
Nilotinib—Vomiting—Perindopril—hypertension	7.8e-06	5.68e-05	CcSEcCtD
Nilotinib—Abdominal pain—Ramipril—hypertension	7.8e-06	5.68e-05	CcSEcCtD
Nilotinib—Body temperature increased—Ramipril—hypertension	7.8e-06	5.68e-05	CcSEcCtD
Nilotinib—Decreased appetite—Lisinopril—hypertension	7.78e-06	5.66e-05	CcSEcCtD
Nilotinib—Vomiting—Irbesartan—hypertension	7.78e-06	5.66e-05	CcSEcCtD
Nilotinib—Rash—Perindopril—hypertension	7.74e-06	5.63e-05	CcSEcCtD
Nilotinib—Dermatitis—Perindopril—hypertension	7.73e-06	5.62e-05	CcSEcCtD
Nilotinib—Gastrointestinal disorder—Lisinopril—hypertension	7.73e-06	5.62e-05	CcSEcCtD
Nilotinib—Nausea—Telmisartan—hypertension	7.72e-06	5.62e-05	CcSEcCtD
Nilotinib—Fatigue—Lisinopril—hypertension	7.72e-06	5.61e-05	CcSEcCtD
Nilotinib—Vomiting—Hydrochlorothiazide—hypertension	7.71e-06	5.61e-05	CcSEcCtD
Nilotinib—Rash—Irbesartan—hypertension	7.71e-06	5.61e-05	CcSEcCtD
Nilotinib—Dermatitis—Irbesartan—hypertension	7.7e-06	5.61e-05	CcSEcCtD
Nilotinib—Headache—Perindopril—hypertension	7.69e-06	5.59e-05	CcSEcCtD
Nilotinib—Urticaria—Timolol—hypertension	7.66e-06	5.58e-05	CcSEcCtD
Nilotinib—Headache—Irbesartan—hypertension	7.66e-06	5.57e-05	CcSEcCtD
Nilotinib—Constipation—Lisinopril—hypertension	7.65e-06	5.57e-05	CcSEcCtD
Nilotinib—Pain—Lisinopril—hypertension	7.65e-06	5.57e-05	CcSEcCtD
Nilotinib—Rash—Hydrochlorothiazide—hypertension	7.65e-06	5.57e-05	CcSEcCtD
Nilotinib—Dermatitis—Hydrochlorothiazide—hypertension	7.64e-06	5.56e-05	CcSEcCtD
Nilotinib—Abdominal pain—Timolol—hypertension	7.63e-06	5.55e-05	CcSEcCtD
Nilotinib—Body temperature increased—Timolol—hypertension	7.63e-06	5.55e-05	CcSEcCtD
Nilotinib—Dizziness—Losartan—hypertension	7.61e-06	5.54e-05	CcSEcCtD
Nilotinib—Headache—Hydrochlorothiazide—hypertension	7.6e-06	5.53e-05	CcSEcCtD
Nilotinib—Vomiting—Furosemide—hypertension	7.58e-06	5.52e-05	CcSEcCtD
Nilotinib—Rash—Furosemide—hypertension	7.52e-06	5.47e-05	CcSEcCtD
Nilotinib—Dermatitis—Furosemide—hypertension	7.51e-06	5.47e-05	CcSEcCtD
Nilotinib—Vomiting—Betaxolol—hypertension	7.51e-06	5.46e-05	CcSEcCtD
Nilotinib—Nausea—Captopril—hypertension	7.51e-06	5.46e-05	CcSEcCtD
Nilotinib—Headache—Furosemide—hypertension	7.47e-06	5.44e-05	CcSEcCtD
Nilotinib—Rash—Betaxolol—hypertension	7.45e-06	5.42e-05	CcSEcCtD
Nilotinib—Dermatitis—Betaxolol—hypertension	7.44e-06	5.41e-05	CcSEcCtD
Nilotinib—Headache—Betaxolol—hypertension	7.4e-06	5.38e-05	CcSEcCtD
Nilotinib—Feeling abnormal—Lisinopril—hypertension	7.38e-06	5.37e-05	CcSEcCtD
Nilotinib—Gastrointestinal pain—Lisinopril—hypertension	7.32e-06	5.33e-05	CcSEcCtD
Nilotinib—Vomiting—Losartan—hypertension	7.32e-06	5.32e-05	CcSEcCtD
Nilotinib—Nausea—Perindopril—hypertension	7.29e-06	5.3e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Ramipril—hypertension	7.27e-06	5.29e-05	CcSEcCtD
Nilotinib—Nausea—Irbesartan—hypertension	7.26e-06	5.29e-05	CcSEcCtD
Nilotinib—Rash—Losartan—hypertension	7.26e-06	5.28e-05	CcSEcCtD
Nilotinib—Dermatitis—Losartan—hypertension	7.25e-06	5.28e-05	CcSEcCtD
Nilotinib—Headache—Losartan—hypertension	7.21e-06	5.25e-05	CcSEcCtD
Nilotinib—Nausea—Hydrochlorothiazide—hypertension	7.2e-06	5.24e-05	CcSEcCtD
Nilotinib—Urticaria—Lisinopril—hypertension	7.11e-06	5.17e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Timolol—hypertension	7.11e-06	5.17e-05	CcSEcCtD
Nilotinib—Nausea—Furosemide—hypertension	7.09e-06	5.16e-05	CcSEcCtD
Nilotinib—Asthenia—Ramipril—hypertension	7.08e-06	5.15e-05	CcSEcCtD
Nilotinib—Body temperature increased—Lisinopril—hypertension	7.08e-06	5.15e-05	CcSEcCtD
Nilotinib—Abdominal pain—Lisinopril—hypertension	7.08e-06	5.15e-05	CcSEcCtD
Nilotinib—Nausea—Betaxolol—hypertension	7.01e-06	5.1e-05	CcSEcCtD
Nilotinib—Pruritus—Ramipril—hypertension	6.98e-06	5.08e-05	CcSEcCtD
Nilotinib—Asthenia—Timolol—hypertension	6.92e-06	5.04e-05	CcSEcCtD
Nilotinib—Nausea—Losartan—hypertension	6.84e-06	4.97e-05	CcSEcCtD
Nilotinib—Pruritus—Timolol—hypertension	6.83e-06	4.97e-05	CcSEcCtD
Nilotinib—Diarrhoea—Ramipril—hypertension	6.75e-06	4.91e-05	CcSEcCtD
Nilotinib—Diarrhoea—Timolol—hypertension	6.6e-06	4.8e-05	CcSEcCtD
Nilotinib—Hypersensitivity—Lisinopril—hypertension	6.59e-06	4.8e-05	CcSEcCtD
Nilotinib—Dizziness—Ramipril—hypertension	6.53e-06	4.75e-05	CcSEcCtD
Nilotinib—Asthenia—Lisinopril—hypertension	6.42e-06	4.67e-05	CcSEcCtD
Nilotinib—Dizziness—Timolol—hypertension	6.38e-06	4.64e-05	CcSEcCtD
Nilotinib—Pruritus—Lisinopril—hypertension	6.33e-06	4.61e-05	CcSEcCtD
Nilotinib—Vomiting—Ramipril—hypertension	6.27e-06	4.57e-05	CcSEcCtD
Nilotinib—Rash—Ramipril—hypertension	6.22e-06	4.53e-05	CcSEcCtD
Nilotinib—Dermatitis—Ramipril—hypertension	6.22e-06	4.52e-05	CcSEcCtD
Nilotinib—Headache—Ramipril—hypertension	6.18e-06	4.5e-05	CcSEcCtD
Nilotinib—Vomiting—Timolol—hypertension	6.13e-06	4.46e-05	CcSEcCtD
Nilotinib—Diarrhoea—Lisinopril—hypertension	6.12e-06	4.46e-05	CcSEcCtD
Nilotinib—Rash—Timolol—hypertension	6.08e-06	4.43e-05	CcSEcCtD
Nilotinib—Dermatitis—Timolol—hypertension	6.08e-06	4.42e-05	CcSEcCtD
Nilotinib—Headache—Timolol—hypertension	6.04e-06	4.4e-05	CcSEcCtD
Nilotinib—Dizziness—Lisinopril—hypertension	5.92e-06	4.31e-05	CcSEcCtD
Nilotinib—Nausea—Ramipril—hypertension	5.86e-06	4.27e-05	CcSEcCtD
Nilotinib—Nausea—Timolol—hypertension	5.73e-06	4.17e-05	CcSEcCtD
Nilotinib—Vomiting—Lisinopril—hypertension	5.69e-06	4.14e-05	CcSEcCtD
Nilotinib—Rash—Lisinopril—hypertension	5.64e-06	4.11e-05	CcSEcCtD
Nilotinib—Dermatitis—Lisinopril—hypertension	5.64e-06	4.1e-05	CcSEcCtD
Nilotinib—Headache—Lisinopril—hypertension	5.61e-06	4.08e-05	CcSEcCtD
Nilotinib—Nausea—Lisinopril—hypertension	5.32e-06	3.87e-05	CcSEcCtD
Nilotinib—ABCB1—Metabolism—LPL—hypertension	2.98e-07	2.75e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GNAS—hypertension	2.98e-07	2.74e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—VEGFA—hypertension	2.98e-07	2.74e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—CDKN1A—hypertension	2.98e-07	2.74e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—PTEN—hypertension	2.97e-07	2.74e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PPARG—hypertension	2.95e-07	2.72e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOB—hypertension	2.94e-07	2.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—IL6—hypertension	2.94e-07	2.71e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Immune System—AKT1—hypertension	2.94e-07	2.71e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC9A1—hypertension	2.94e-07	2.71e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTT1—hypertension	2.94e-07	2.71e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—AGT—hypertension	2.93e-07	2.7e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MMP9—hypertension	2.93e-07	2.7e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ADCY5—hypertension	2.92e-07	2.69e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOB—hypertension	2.92e-07	2.69e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—CDKN1A—hypertension	2.91e-07	2.69e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—POMC—hypertension	2.91e-07	2.68e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—GPX1—hypertension	2.91e-07	2.68e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—PTEN—hypertension	2.91e-07	2.68e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MAPK8—hypertension	2.91e-07	2.68e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CETP—hypertension	2.9e-07	2.68e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GCLC—hypertension	2.9e-07	2.68e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—MYC—hypertension	2.89e-07	2.67e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—INS—hypertension	2.89e-07	2.67e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TGFB1—hypertension	2.89e-07	2.66e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—IL6—hypertension	2.88e-07	2.65e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PRKCA—hypertension	2.88e-07	2.65e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CYP1A1—hypertension	2.88e-07	2.65e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CALM1—hypertension	2.88e-07	2.65e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—IL6—hypertension	2.87e-07	2.64e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOE—hypertension	2.87e-07	2.64e-06	CbGpPWpGaD
Nilotinib—KIT—Disease—AKT1—hypertension	2.87e-07	2.64e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GSTM1—hypertension	2.86e-07	2.64e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MAPK8—hypertension	2.84e-07	2.62e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—CAV1—hypertension	2.84e-07	2.62e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GSTM1—hypertension	2.84e-07	2.61e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—APOA1—hypertension	2.84e-07	2.61e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EP300—hypertension	2.83e-07	2.61e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CD36—hypertension	2.83e-07	2.61e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—EGFR—hypertension	2.83e-07	2.61e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—MYC—hypertension	2.83e-07	2.61e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—TGFB1—hypertension	2.82e-07	2.6e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—RELA—hypertension	2.81e-07	2.59e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—IL6—hypertension	2.81e-07	2.59e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—LPL—hypertension	2.81e-07	2.59e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—IL6—hypertension	2.8e-07	2.58e-06	CbGpPWpGaD
Nilotinib—MAPK8—Signaling Pathways—AKT1—hypertension	2.79e-07	2.57e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—LPL—hypertension	2.78e-07	2.57e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP17A1—hypertension	2.78e-07	2.56e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EP300—hypertension	2.77e-07	2.56e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MMP9—hypertension	2.77e-07	2.56e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—EGFR—hypertension	2.77e-07	2.55e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—CDKN1A—hypertension	2.76e-07	2.55e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—PTEN—hypertension	2.76e-07	2.54e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MTOR—hypertension	2.76e-07	2.54e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—PTEN—hypertension	2.76e-07	2.54e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—SRC—hypertension	2.75e-07	2.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ENO1—hypertension	2.75e-07	2.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS1—hypertension	2.75e-07	2.54e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ADCY5—hypertension	2.75e-07	2.53e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—GPX1—hypertension	2.74e-07	2.53e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—MYC—hypertension	2.74e-07	2.52e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TGFB1—hypertension	2.73e-07	2.52e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ADCY5—hypertension	2.73e-07	2.51e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—GPX1—hypertension	2.72e-07	2.5e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Disease—AKT1—hypertension	2.71e-07	2.5e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CYP1A1—hypertension	2.71e-07	2.5e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PRKCA—hypertension	2.71e-07	2.5e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MAPK8—hypertension	2.7e-07	2.49e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—SRC—hypertension	2.7e-07	2.49e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PRKCA—hypertension	2.69e-07	2.48e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CYP1A1—hypertension	2.69e-07	2.48e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—MTHFR—hypertension	2.68e-07	2.47e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—VEGFA—hypertension	2.68e-07	2.47e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—EGFR—hypertension	2.68e-07	2.47e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CD36—hypertension	2.67e-07	2.46e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—IL6—hypertension	2.66e-07	2.45e-06	CbGpPWpGaD
Nilotinib—MAP2K5—Signaling Pathways—AKT1—hypertension	2.66e-07	2.45e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—ALB—hypertension	2.65e-07	2.44e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CXCL8—hypertension	2.65e-07	2.44e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—IL6—hypertension	2.65e-07	2.44e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CTGF—hypertension	2.65e-07	2.44e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Immune System—AKT1—hypertension	2.65e-07	2.44e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CD36—hypertension	2.65e-07	2.44e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—TP53—hypertension	2.64e-07	2.43e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—EP300—hypertension	2.63e-07	2.43e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PPARA—hypertension	2.63e-07	2.43e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EP300—hypertension	2.63e-07	2.42e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—VEGFA—hypertension	2.63e-07	2.42e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMGCR—hypertension	2.63e-07	2.42e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT2—hypertension	2.63e-07	2.42e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—TP53—hypertension	2.61e-07	2.41e-06	CbGpPWpGaD
Nilotinib—LYN—Immune System—AKT1—hypertension	2.59e-07	2.39e-06	CbGpPWpGaD
Nilotinib—ABL1—Immune System—AKT1—hypertension	2.58e-07	2.38e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADRA2A—hypertension	2.57e-07	2.37e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—SRC—hypertension	2.56e-07	2.36e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—AGT—hypertension	2.55e-07	2.35e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PIK3R1—hypertension	2.54e-07	2.34e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—NOS3—hypertension	2.54e-07	2.34e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—MTHFR—hypertension	2.53e-07	2.33e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CALM1—hypertension	2.51e-07	2.31e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—MTHFR—hypertension	2.51e-07	2.31e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOE—hypertension	2.5e-07	2.3e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PPARG—hypertension	2.5e-07	2.3e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—VEGFA—hypertension	2.49e-07	2.29e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PPARA—hypertension	2.48e-07	2.29e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—CAV1—hypertension	2.48e-07	2.28e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—APOA1—hypertension	2.47e-07	2.28e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—MYC—hypertension	2.47e-07	2.27e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—POMC—hypertension	2.46e-07	2.27e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TGFB1—hypertension	2.46e-07	2.27e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PPARA—hypertension	2.46e-07	2.27e-06	CbGpPWpGaD
Nilotinib—MAPK14—Immune System—AKT1—hypertension	2.46e-07	2.26e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—INS—hypertension	2.45e-07	2.26e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Disease—AKT1—hypertension	2.44e-07	2.25e-06	CbGpPWpGaD
Nilotinib—MAPK14—Gene Expression—AKT1—hypertension	2.44e-07	2.25e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—MYC—hypertension	2.42e-07	2.23e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—EGFR—hypertension	2.41e-07	2.22e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—IL6—hypertension	2.41e-07	2.22e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TGFB1—hypertension	2.41e-07	2.22e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—TH—hypertension	2.41e-07	2.22e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—AGT—hypertension	2.4e-07	2.21e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MMP9—hypertension	2.4e-07	2.21e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CALM2—hypertension	2.4e-07	2.21e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—IL6—hypertension	2.39e-07	2.2e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—CDKN1A—hypertension	2.39e-07	2.2e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—PTEN—hypertension	2.38e-07	2.2e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—AGT—hypertension	2.38e-07	2.2e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—TP53—hypertension	2.38e-07	2.19e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—EGFR—hypertension	2.36e-07	2.18e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CALM1—hypertension	2.36e-07	2.18e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOE—hypertension	2.35e-07	2.17e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CALM1—hypertension	2.34e-07	2.16e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GCG—hypertension	2.34e-07	2.16e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—SLC2A4—hypertension	2.34e-07	2.16e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOE—hypertension	2.33e-07	2.15e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—CAV1—hypertension	2.33e-07	2.15e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MAPK8—hypertension	2.33e-07	2.15e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—APOA1—hypertension	2.33e-07	2.14e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTGS2—hypertension	2.32e-07	2.14e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—CAV1—hypertension	2.31e-07	2.13e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—APOA1—hypertension	2.31e-07	2.13e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—IL6—hypertension	2.3e-07	2.12e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—MYC—hypertension	2.29e-07	2.11e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TGFB1—hypertension	2.29e-07	2.11e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EP300—hypertension	2.27e-07	2.09e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GOT1—hypertension	2.27e-07	2.09e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—TP53—hypertension	2.25e-07	2.07e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—ALB—hypertension	2.25e-07	2.07e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—EGFR—hypertension	2.24e-07	2.06e-06	CbGpPWpGaD
Nilotinib—MAPK11—Signaling Pathways—AKT1—hypertension	2.23e-07	2.05e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—SRC—hypertension	2.21e-07	2.04e-06	CbGpPWpGaD
Nilotinib—BRAF—Signaling Pathways—AKT1—hypertension	2.21e-07	2.03e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—STK11—hypertension	2.2e-07	2.03e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP19A1—hypertension	2.2e-07	2.03e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PPARG—hypertension	2.18e-07	2.01e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—IL6—hypertension	2.18e-07	2e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—VEGFA—hypertension	2.15e-07	1.98e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PIK3R1—hypertension	2.15e-07	1.98e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—NOS3—hypertension	2.15e-07	1.98e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—POMC—hypertension	2.15e-07	1.98e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—INS—hypertension	2.13e-07	1.97e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—IL6—hypertension	2.13e-07	1.96e-06	CbGpPWpGaD
Nilotinib—LCK—Immune System—AKT1—hypertension	2.12e-07	1.96e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—IL6—hypertension	2.06e-07	1.9e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PPARG—hypertension	2.05e-07	1.89e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—COMT—hypertension	2.05e-07	1.89e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PPARG—hypertension	2.03e-07	1.87e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—TP53—hypertension	2.03e-07	1.87e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—PTEN—hypertension	2.02e-07	1.87e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—POMC—hypertension	2.02e-07	1.86e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GNB3—hypertension	2.02e-07	1.86e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPARGC1A—hypertension	2.02e-07	1.86e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—INS—hypertension	2.01e-07	1.85e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—HMOX1—hypertension	2.01e-07	1.85e-06	CbGpPWpGaD
Nilotinib—KIT—Signaling Pathways—AKT1—hypertension	2.01e-07	1.85e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—POMC—hypertension	2.01e-07	1.85e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—INS—hypertension	1.99e-07	1.84e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—TP53—hypertension	1.98e-07	1.83e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAT—hypertension	1.98e-07	1.83e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—MYC—hypertension	1.98e-07	1.83e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TGFB1—hypertension	1.98e-07	1.82e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTGS2—hypertension	1.97e-07	1.81e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GNAS—hypertension	1.96e-07	1.81e-06	CbGpPWpGaD
Nilotinib—LCK—Disease—AKT1—hypertension	1.96e-07	1.81e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—ALB—hypertension	1.96e-07	1.8e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—EGFR—hypertension	1.94e-07	1.79e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—EP300—hypertension	1.93e-07	1.78e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOB—hypertension	1.92e-07	1.77e-06	CbGpPWpGaD
Nilotinib—PDGFRA—Signaling Pathways—AKT1—hypertension	1.9e-07	1.75e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—TP53—hypertension	1.88e-07	1.73e-06	CbGpPWpGaD
Nilotinib—UGT1A1—Metabolism—AKT1—hypertension	1.88e-07	1.73e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—NOS3—hypertension	1.87e-07	1.72e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PIK3R1—hypertension	1.87e-07	1.72e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GSTM1—hypertension	1.87e-07	1.72e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—IL6—hypertension	1.86e-07	1.71e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—ALB—hypertension	1.84e-07	1.7e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—LPL—hypertension	1.84e-07	1.69e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—ALB—hypertension	1.83e-07	1.68e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—IL6—hypertension	1.82e-07	1.67e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ADCY5—hypertension	1.8e-07	1.66e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—GPX1—hypertension	1.79e-07	1.65e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PRKCA—hypertension	1.77e-07	1.63e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CYP1A1—hypertension	1.77e-07	1.63e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PIK3R1—hypertension	1.76e-07	1.63e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—NOS3—hypertension	1.76e-07	1.63e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—NOS3—hypertension	1.75e-07	1.61e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PIK3R1—hypertension	1.75e-07	1.61e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CD36—hypertension	1.74e-07	1.61e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—IL6—hypertension	1.72e-07	1.59e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—PTEN—hypertension	1.71e-07	1.58e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTGS2—hypertension	1.71e-07	1.58e-06	CbGpPWpGaD
Nilotinib—PDGFRB—Signaling Pathways—AKT1—hypertension	1.71e-07	1.58e-06	CbGpPWpGaD
Nilotinib—LYN—Signaling Pathways—AKT1—hypertension	1.68e-07	1.54e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—MTHFR—hypertension	1.65e-07	1.52e-06	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—EP300—hypertension	1.63e-07	1.51e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—TP53—hypertension	1.63e-07	1.5e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPARA—hypertension	1.62e-07	1.49e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTGS2—hypertension	1.61e-07	1.49e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTGS2—hypertension	1.6e-07	1.47e-06	CbGpPWpGaD
Nilotinib—ABCG2—Metabolism—AKT1—hypertension	1.59e-07	1.47e-06	CbGpPWpGaD
Nilotinib—MAPK14—Signaling Pathways—AKT1—hypertension	1.59e-07	1.46e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—AGT—hypertension	1.57e-07	1.45e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CALM1—hypertension	1.54e-07	1.42e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOE—hypertension	1.54e-07	1.42e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—CAV1—hypertension	1.53e-07	1.41e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—APOA1—hypertension	1.52e-07	1.4e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—PTEN—hypertension	1.49e-07	1.38e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—IL6—hypertension	1.49e-07	1.37e-06	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—EP300—hypertension	1.42e-07	1.31e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—PTEN—hypertension	1.41e-07	1.3e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—PTEN—hypertension	1.39e-07	1.29e-06	CbGpPWpGaD
Nilotinib—LCK—Signaling Pathways—AKT1—hypertension	1.37e-07	1.27e-06	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—EP300—hypertension	1.34e-07	1.24e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PPARG—hypertension	1.34e-07	1.24e-06	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—EP300—hypertension	1.33e-07	1.23e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—POMC—hypertension	1.32e-07	1.22e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—INS—hypertension	1.32e-07	1.21e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—ALB—hypertension	1.21e-07	1.11e-06	CbGpPWpGaD
Nilotinib—CYP2B6—Metabolism—AKT1—hypertension	1.17e-07	1.08e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PIK3R1—hypertension	1.15e-07	1.06e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—NOS3—hypertension	1.15e-07	1.06e-06	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTGS2—hypertension	1.05e-07	9.72e-07	CbGpPWpGaD
Nilotinib—CYP2C8—Metabolism—AKT1—hypertension	9.88e-08	9.1e-07	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—PTEN—hypertension	9.2e-08	8.48e-07	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—EP300—hypertension	8.77e-08	8.08e-07	CbGpPWpGaD
Nilotinib—ABCB1—Metabolism—AKT1—hypertension	8.6e-08	7.93e-07	CbGpPWpGaD
Nilotinib—CYP2D6—Metabolism—AKT1—hypertension	8.11e-08	7.47e-07	CbGpPWpGaD
Nilotinib—CYP2C9—Metabolism—AKT1—hypertension	8.04e-08	7.41e-07	CbGpPWpGaD
Nilotinib—CYP3A4—Metabolism—AKT1—hypertension	5.3e-08	4.89e-07	CbGpPWpGaD
